There are mainy drivers for the development of controlled release products. These can be both clinical and product driven.

• Clinical needs for specific plasma time-course profiles
• Avoidance of site-specific degradation in the gastro-intestinal tract
• Targeted delivery need
• Improvement of patient compliance
• Line extensions to extend the life cycle of existing brands
  
• Compatibility issues for multi-component products
• Availability of new technologies

Encap can offer both non-IP and IP based solutions for controlled release products.  By using appropriate excipients, we can produce liquid and semi-solid formulations which can modify the rate in which an active is released.  These formulations can be filled into hard gelatin capsules which can also be coated with an appropriate material to ensure that the active is only released at a specific site within the GI tract.  This offers a huge range of options available for delivering the active in the optimal way.

In addition Encap can offer several novel IP based drug delivery technologies. 

DuoCap - The only dual capsule system available to the pharmaceutical and nutraceutical industry

LayerCap - Multiphase release from a single capsule

Abusolve - Providing deterrance for drug products that are subject to abuse

ENCODE - A range of novel coating systems designed to specifically delivery drugs to the colon

Enteric - Encap also has a range of solutions designed to ensure that the drug product is protected from the stomach and delivered into the small intestine